1. 1632P_PRCharacterizing the risk of drug-drug interactions in sarcoma treated patients: Role of pharmacist integration. (23rd October 2018) Authors: Bellesoeur, A; Gataa, I; Jouinot, A; El Mershati, S; Arrondeau, J; Tlemsani, C; Blanchet, B; Alexandre, J; Goldwasser, F; Thomas-Schoemann, A; Boudou Rouquette, P Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 265TiPKEYNOTE-826: A phase III randomized study of chemotherapy with or without pembrolizumab for first-line treatment of persistent, recurrent, or metastatic cervical cancer. (24th November 2019) Authors: Fujiwara, K; Shapira-Frommer, R; Alexandre, J; Monk, B; Fehm, T; Colombo, N; Caceres, M V; Hasegawa, K; Dubot, C; Li, J J; Stein, K; Keefe, S M; Tewari, K Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 393 Keynote-826: a phase 3, randomized, double-blind, placebo-controlled study of pembrolizumab plus chemotherapy for first-line treatment of persistent, recurrent, or metastatic cervical cancer. (18th September 2019) Authors: Tewari, K; Caceres, MV; Alexandre, J; Monk, B; Fehm, T; Colombo, N; Hasegawa, K; Dubot, C; Li, JJ; Stein, K; Keefe, S; Shapira-Frommer, R Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 3 Page Start: A162 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 851PPharmacokinetic/pharmacodynamic relationship of enzalutamide and its active metabolite N-desmethyl enzalutamide in metastatic castration-resistant prostate cancer patients. (23rd October 2018) Authors: Joulia, M-L; Carton Vienet Legue, E; Allard, M; Huillard, O; Peyromaure, M; Zerbib, M; Vidal, M; Goldwasser, F; Alexandre, J; Blanchet, B Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 938PDNeed for a stratified analysis in stage I malignant ovarian germ cell tumors (MOGCT): Prospective survival analysis of cases collection from the French rare malignant ovarian tumors (TMRO) network & GINECO group. (23rd October 2018) Authors: de la Motte Rouge, T; Derquin, F; Floquet, A; Edeline, J; Lotz, J-P; Alexandre, J; Pautier, P; Ferron, G; Boissier, E; Lefeuvre-Plesse, C; Vegas, H; Patsouris, A; Kalbacher, E; Berton-Rigaud, D; Hardy Bessard, A-C; Lavoué, V; Ray-Coquard, I L Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. CP-240 The clinical pharmacist resolves medication relative problems in oncologic patients. is it true?. (25th February 2017) Authors: Borja-Prats, C; Conort, O; Maire, A; Jouinot, A; Thomas-Schoemann, A; Alexandre, J; Brandely, M; Batista, R; Bardin, C Journal: European journal of hospital pharmacy Issue: Volume 24(2017)Supplement 1 Page Start: A108 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Definition of left ventricular remodelling following ST-elevation myocardial infarction: a systematic review of cardiac magnetic resonance studies. (25th November 2020) Authors: Legallois, D; Hodzic, A; Alexandre, J; Dolladille, C; Saloux, E; Manrique, A; Roule, V; Labombarda, F; Milliez, P; Beygui, F Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Effective fermion kinematics from modified quantum gravity. (8th September 2016) Authors: Alexandre, J; Leite, J Journal: Classical and quantum gravity Issue: Volume 33:Number 19(2016:Oct.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial. Issue 1 (January 2022) Authors: Verma, Subodh; Dhingra, Nitish K; Butler, Javed; Anker, Stefan D; Ferreira, Joao Pedro; Filippatos, Gerasimos; Januzzi, James L; Lam, Carolyn S P; Sattar, Naveed; Peil, Barbara; Nordaby, Matias; Brueckmann, Martina; Pocock, Stuart J; Zannad, Faiez; Packer, Milton; Packer, M; Anker, S; Butler, J; ... Journal: Lancet Issue: Volume 10:Issue 1(2022) Page Start: 35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Focus on cannabinoids and synthetic cannabinoids. Issue 2 (20th December 2016) Authors: Le Boisselier, R; Alexandre, J; Lelong‐Boulouard, V; Debruyne, D Journal: Clinical pharmacology & therapeutics Issue: Volume 101:Issue 2(2017) Page Start: 220 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗